Statins and primary liver cancer

Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection

(2012) Yu-Tse Tsan et al.   JOURNAL OF CLINICAL ONCOLOGY

Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy

(2012)   PLoS One

MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase

(2011) Z. Cao et al.   CANCER RESEARCH

Statin Use and the Risk of Liver Cancer: A Population-Based Case–Control Study

(2010) Hui-Fen Chiu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Statin use and cancer risk: a comprehensive review

(2010) Denise M Boudreau et al.   Expert Opinion On Drug Safety

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes

(2009) Hashem B. El–Serag et al.   GASTROENTEROLOGY

Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection

(2008) Shu-Chun Chuang et al.   CANCER LETTERS

Statins and cancer: A systematic review and meta-analysis

(2008) Jaana Kuoppala et al.   EUROPEAN JOURNAL OF CANCER

Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004

(2008) Cristina Bosetti et al.   HEPATOLOGY